Pediatric Testing
Newborn Screening Panel 2 Test
The Newborn Screening Panel 2 Test checks for Thyroid-Stimulating Hormone (TSH) and Glucose-6-Phosphate Dehydrogenase (G-6PD) levels in newborns to detect potential metabolic disorders early. Early detection allows for timely intervention and management.
General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.
Review status: No completed medical review is recorded for this page.
At a glance
Plan your test
- Sample
- Blood sample collected via heel prick.
- Results
- Confirm with the laboratory before booking.
- Preparation
- No special preparation is required for the newborn.
Payment: M-Pesa and card options can be confirmed during booking.
Insurance & government schemes
Is this test covered for you?
We help you verify whether the Newborn Screening Panel 2 Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.
Providers & schemes we can help you check
Government & public schemes
Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.
Private insurers & employer schemes
Names shown for identification only — listing does not imply partnership or guarantee of coverage.
Have these ready when we check
- Insurer or scheme name & policy / member number
- A clinician's request / prescription for the test
- Pre-authorisation letter, if your plan requires one
Free coverage check
Ask us to verify your cover
Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.
Start with fit
Is this the right test for you?
The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.
- ✓Newborn screening
- ✓Family history of metabolic disorders
- ✓Symptoms like jaundice, lethargy, or feeding difficulties
- ✓Clinical concerns raised by healthcare providers
In plain language
What this test helps you understand
This test specifically measures the levels of Thyroid-Stimulating Hormone (TSH) and Glucose-6-Phosphate Dehydrogenase (G-6PD) in a newborn's blood. Abnormal levels of these markers can indicate potential metabolic disorders that require further evaluation and management.
All newborns should ideally undergo newborn screening. This test is particularly recommended for infants with a family history of metabolic disorders, those showing symptoms like jaundice, lethargy, or feeding difficulties, or any other clinical concerns raised by healthcare providers.
Benefits of this screening include the early identification of metabolic disorders, enabling timely treatment options to prevent serious health issues, providing peace of mind for parents, and offering a comprehensive assessment of the newborn's health.
Medical review status
Clinical review pending
A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.
Meet the DNA Labs Kenya medical team →A simple process
What happens next?
You do not have to navigate the test alone. We help you move from question to next step.
Speak with us
We check the test and answer your questions before collection.
Give your sample
Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.
Understand your report
A counselor helps you understand the result and the next steps.
Choose your collection
Home collection or a lab visit
We will explain the sample, preparation, and next steps before anything is collected.
Home collection
Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.
Lab or hub visit
Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.
Ask about locations →Read your report
What common result terms mean
Questions people ask
Frequently asked questions
Collaboration
Open for partnership with hospitals, clinics, doctors & researchers
Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.
Hospitals & clinics
Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.
Doctors & specialists
LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.
Research institutions
Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.
Students & academic projects
Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.
Trust & transparency
Sources, standards & how this page is maintained
Standards & references
- ACMG/AMP technical standards for sequence variant interpretation
- ClinGen curation and gene–disease validity frameworks where applicable
- LOINC-coded reporting for interoperable results
- ISO 9001:2015 quality management; ISO 15189 accreditation in progress
Page provenance
- Last updated: September 27, 2026
- Medical review: not yet completed
- Written for patients & clinicians in Kenya; reviewed periodically against current guidance
Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.
Keep exploring
Related tests
VANGL1 Gene Caudal Regression Syndrome Genetic Test
This genetic test identifies mutations in the VANGL1 gene associated with caudal regression syndrome using Next Generation Sequencing (NGS). It is recommended for individuals or families with a history of this condition or related dysmorphological features.
Learn more →Periodontal Multiplex Detection Differentiation Porphyromonas Gingivalis Treponema Denticola Tannerella Forsythia Fusobacterium Nucleatum RNA Detection Qualitative Test
This test identifies specific bacteria linked to gum disease using advanced RNA detection technology. It helps guide targeted treatment for better oral health.
Learn more →